|
US9321832B2
(en)
*
|
2002-06-28 |
2016-04-26 |
Domantis Limited |
Ligand
|
|
US9028822B2
(en)
|
2002-06-28 |
2015-05-12 |
Domantis Limited |
Antagonists against TNFR1 and methods of use therefor
|
|
US9320792B2
(en)
|
2002-11-08 |
2016-04-26 |
Ablynx N.V. |
Pulmonary administration of immunoglobulin single variable domains and constructs thereof
|
|
NZ540194A
(en)
|
2002-11-08 |
2008-07-31 |
Ablynx Nv |
Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
|
|
EP1558645B1
(en)
*
|
2002-11-08 |
2011-07-27 |
Ablynx N.V. |
Stabilized single domain antibodies in pharmaceutical composition adapted for inhalation
|
|
US20060034845A1
(en)
|
2002-11-08 |
2006-02-16 |
Karen Silence |
Single domain antibodies directed against tumor necrosis factor alpha and uses therefor
|
|
GB0521621D0
(en)
|
2005-10-24 |
2005-11-30 |
Domantis Ltd |
Tumor necrosis factor receptor 1 antagonists for treating respiratory diseases
|
|
JP2009517069A
(ja)
*
|
2005-12-01 |
2009-04-30 |
ドマンティス リミテッド |
インターロイキン１受容体１型に結合する競合ドメイン抗体フォーマット
|
|
CA2632866A1
(en)
*
|
2005-12-01 |
2007-06-07 |
Domantis Limited |
Noncompetitive domain antibody formats that bind interleukin 1 receptor type 1
|
|
PT2068889T
(pt)
*
|
2006-08-10 |
2020-01-30 |
Roy C Levitt |
Anakinra para uso no tratamento da síndrome da bronquiolite obliterante
|
|
AU2013270447B2
(en)
*
|
2006-08-10 |
2016-10-13 |
Onspira Therapeutics, Inc. |
Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors
|
|
GB0621513D0
(en)
*
|
2006-10-30 |
2006-12-06 |
Domantis Ltd |
Novel polypeptides and uses thereof
|
|
GB0724331D0
(en)
|
2007-12-13 |
2008-01-23 |
Domantis Ltd |
Compositions for pulmonary delivery
|
|
CA2688434A1
(en)
*
|
2007-06-06 |
2008-12-11 |
Domantis Limited |
Polypeptides, antibody variable domains and antagonists
|
|
WO2009033667A2
(en)
*
|
2007-09-11 |
2009-03-19 |
Mondobiotech Laboratories Ag |
Use of a peptide as a therapeutic agent
|
|
JP2011505335A
(ja)
*
|
2007-09-11 |
2011-02-24 |
モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト |
治療剤としてのＴＲＰ−６−トリプトレリンおよびＤ−Ｌｅｕ６−ロイプロリドの使用
|
|
EP2220115A2
(en)
*
|
2007-12-13 |
2010-08-25 |
Glaxo Group Limited |
Polypeptides, antibody variable domains & antagonists
|
|
US8753690B2
(en)
|
2008-02-27 |
2014-06-17 |
Biomet Biologics, Llc |
Methods and compositions for delivering interleukin-1 receptor antagonist
|
|
WO2009108890A1
(en)
|
2008-02-27 |
2009-09-03 |
Biomet Biologics, Llc |
Methods and compositions for delivering interleukin-1 receptor antagonist
|
|
CA2721202A1
(en)
|
2008-04-17 |
2009-10-22 |
Hilde Adi Pierrette Revets |
Peptides capable of binding to serum proteins and compounds, constructs and polypeptides comprising the same
|
|
WO2010046337A2
(en)
*
|
2008-10-21 |
2010-04-29 |
Domantis Limited |
Ligands that have binding specificity for dc-sign
|
|
RU2481824C2
(ru)
|
2008-10-29 |
2013-05-20 |
Аблинкс Н.В |
Препараты однодоменных антигенсвязывающих молекул
|
|
CN105646643A
(zh)
|
2008-10-29 |
2016-06-08 |
阿布林克斯公司 |
单域抗原结合性分子的纯化方法
|
|
US8298533B2
(en)
*
|
2008-11-07 |
2012-10-30 |
Medimmune Limited |
Antibodies to IL-1R1
|
|
WO2010056732A1
(en)
|
2008-11-12 |
2010-05-20 |
Marv Enterprises Llc |
Utilization of stents for the treatment of blood borne carcinomas
|
|
ES2701649T3
(es)
*
|
2009-01-14 |
2019-02-25 |
Ablynx Nv |
Administración pulmonar de dominios variables individuales de inmunoglobulina y constructos de los mismos
|
|
WO2010107789A1
(en)
*
|
2009-03-17 |
2010-09-23 |
Marv Enterprises Llc |
Sequential extracorporeal treatment of bodily fluids
|
|
US20100291106A1
(en)
*
|
2009-05-06 |
2010-11-18 |
Novartis Ag |
Compositions and methods for antibodies targeting complement protein c3b
|
|
CN102459332B
(zh)
*
|
2009-06-05 |
2015-08-19 |
埃博灵克斯股份有限公司 |
用于预防和/或治疗呼吸道感染的单价、二价和三价抗人呼吸道合胞病毒(hrsv)纳米抗体构建体
|
|
JP5844258B2
(ja)
|
2009-08-27 |
2016-01-13 |
バイオメット、バイオロジクス、リミテッド、ライアビリティー、カンパニーＢｉｏｍｅｔ Ｂｉｏｌｏｇｉｃｓ， Ｌｌｃ |
インターロイキン−１受容体アンタゴニストの生産のための植込み型装置
|
|
EP2531523A1
(en)
|
2010-02-05 |
2012-12-12 |
Ablynx N.V. |
Peptides capable of binding to serum albumin and compounds, constructs and polypeptides comprising the same
|
|
MX2012012063A
(es)
*
|
2010-04-16 |
2013-03-21 |
Medimmune Ltd |
Composiciones y metodos para tratar exacerbacion de la enfermedad pulmonar obstructiva cronica (copd).
|
|
KR101333958B1
(ko)
|
2010-10-20 |
2013-11-27 |
주식회사 한독 |
인간 인터루킨-1 수용체 길항제-하이브리드 Ｆｃ 융합단백질
|
|
WO2012053828A2
(ko)
*
|
2010-10-20 |
2012-04-26 |
주식회사 한독약품 |
인간 인터루킨-1 수용체 길항제-하이브리드 Ｆｃ 융합단백질
|
|
US20130266567A1
(en)
*
|
2010-12-01 |
2013-10-10 |
Haren Arulanantham |
Anti-serum albumin binding single variable domains
|
|
JP2014510516A
(ja)
*
|
2011-02-15 |
2014-05-01 |
ノヴォ ノルディスク アー／エス |
長時間作用性ｉｌ−１受容体アンタゴニスト
|
|
EP3363813A1
(en)
|
2011-06-23 |
2018-08-22 |
Ablynx NV |
Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobin single variable domains
|
|
CA3141978A1
(en)
|
2011-06-23 |
2012-12-27 |
Ablynx Nv |
Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
|
|
EP4350345A3
(en)
|
2011-06-23 |
2024-07-24 |
Ablynx N.V. |
Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobin single variable domains
|
|
WO2013148405A2
(en)
*
|
2012-03-27 |
2013-10-03 |
Felder Mitchell S |
Treatment for atherosclerosis
|
|
US9878011B2
(en)
|
2013-03-15 |
2018-01-30 |
Biomet Biologics, Llc |
Treatment of inflammatory respiratory disease using biological solutions
|
|
US10143725B2
(en)
|
2013-03-15 |
2018-12-04 |
Biomet Biologics, Llc |
Treatment of pain using protein solutions
|
|
US9758806B2
(en)
|
2013-03-15 |
2017-09-12 |
Biomet Biologics, Llc |
Acellular compositions for treating inflammatory disorders
|
|
US20140271589A1
(en)
|
2013-03-15 |
2014-09-18 |
Biomet Biologics, Llc |
Treatment of collagen defects using protein solutions
|
|
US9950035B2
(en)
|
2013-03-15 |
2018-04-24 |
Biomet Biologics, Llc |
Methods and non-immunogenic compositions for treating inflammatory disorders
|
|
US9895418B2
(en)
|
2013-03-15 |
2018-02-20 |
Biomet Biologics, Llc |
Treatment of peripheral vascular disease using protein solutions
|
|
US10208095B2
(en)
|
2013-03-15 |
2019-02-19 |
Biomet Manufacturing, Llc |
Methods for making cytokine compositions from tissues using non-centrifugal methods
|
|
WO2015081253A1
(en)
|
2013-11-26 |
2015-06-04 |
Biomet Biologics, Llc |
Methods of mediating macrophage phenotypes
|
|
US11009511B2
(en)
|
2014-05-16 |
2021-05-18 |
Ablynx N.V. |
Methods for detecting and/or measuring anti-drug antibodies, in particular treatment-emergent anti-drug antibodies
|
|
LT3248986T
(lt)
|
2014-05-16 |
2022-03-25 |
Ablynx Nv |
Imunoglobulino kintami domenai
|
|
SG11201702688UA
(en)
|
2014-10-10 |
2017-04-27 |
Ablynx Nv |
Methods of treating rsv infections
|
|
WO2016055655A1
(en)
|
2014-10-10 |
2016-04-14 |
Ablynx N.V. |
Inhalation device for use in aerosol therapy of respiratory diseases
|
|
US9107906B1
(en)
|
2014-10-28 |
2015-08-18 |
Adma Biologics, Inc. |
Compositions and methods for the treatment of immunodeficiency
|
|
US10441635B2
(en)
|
2014-11-10 |
2019-10-15 |
Biomet Biologics, Llc |
Methods of treating pain using protein solutions
|
|
AU2015366284B2
(en)
|
2014-12-19 |
2021-07-22 |
Ablynx N.V. |
Cysteine linked nanobody dimers
|
|
US9763800B2
(en)
|
2015-03-18 |
2017-09-19 |
Biomet C. V. |
Implant configured for hammertoe and small bone fixation
|
|
NO2768984T3
(enExample)
|
2015-11-12 |
2018-06-09 |
|
|
|
HUE057241T2
(hu)
|
2015-11-13 |
2022-04-28 |
Ablynx Nv |
Javított, szérumalbumint kötõ immunoglobulin variábilis domének
|
|
CN108473565B
(zh)
|
2015-11-18 |
2022-05-27 |
默沙东公司 |
Ctla4结合剂
|
|
AU2016357460B2
(en)
|
2015-11-18 |
2023-07-27 |
Ablynx Nv |
Improved serum albumin binders
|
|
WO2017191108A1
(en)
|
2016-05-02 |
2017-11-09 |
Ablynx Nv |
Treatment of rsv infection
|
|
WO2017220645A1
(en)
|
2016-06-23 |
2017-12-28 |
Ablynx N.V. |
Improved pharmacokinetic assays for immunoglobulin single variable domains
|
|
WO2018099968A1
(en)
|
2016-11-29 |
2018-06-07 |
Ablynx N.V. |
Treatment of infection by respiratory syncytial virus (rsv)
|
|
WO2018104444A1
(en)
|
2016-12-07 |
2018-06-14 |
Ablynx Nv |
Improved serum albumin binding immunoglobulin single variable domains
|
|
EP4442709A3
(en)
|
2017-01-17 |
2024-12-25 |
Ablynx NV |
Improved serum albumin binders
|
|
EP3571224B1
(en)
|
2017-01-17 |
2024-08-07 |
Ablynx NV |
Improved serum albumin binders
|
|
US10259865B2
(en)
|
2017-03-15 |
2019-04-16 |
Adma Biologics, Inc. |
Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
|
|
WO2018178307A1
(en)
|
2017-03-31 |
2018-10-04 |
Ablynx N.V. |
Improved immunogenicity assays
|
|
JP7428661B2
(ja)
*
|
2018-05-30 |
2024-02-06 |
中外製薬株式会社 |
Ｉｌ－１ｒ１結合ドメインおよび運搬部分を含むポリペプチド
|
|
EP4144758A4
(en)
|
2020-04-22 |
2024-05-15 |
Mabwell (Shanghai) Bioscience Co., Ltd. |
SINGLE VARIABLE DOMAIN ANTIBODY DIRECTED AGAINST HUMAN PROGRAMMED CELL DEATH LIGAND 1 (PD-L1) AND DERIVATIVE THEREOF
|